These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 8914388)

  • 1. [Chemotherapy of pulmonary Mycobacterium kansasii infection].
    Mizutani S
    Kekkaku; 1996 Sep; 71(9):527-31. PubMed ID: 8914388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Nontuberculous mycobacteriosis; the present status and in the future. 3--(1). The view of development of new drugs against nontuberculous mycobacterial infections].
    Kawahara S; Nagare H
    Kekkaku; 1998 Feb; 73(2):77-82. PubMed ID: 9545700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of non-tuberculous pulmonary mycobacteriosis].
    Sakatani M; Nakajima Y
    Kekkaku; 2006 Jan; 81(1):35-50. PubMed ID: 16479999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Role of new quinolones in the treatment of mycobacteriosis].
    Kekkaku; 2003 Sep; 78(9):601-4. PubMed ID: 14577348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Investigation on the treatment of infection due to Mycobacterium Kansasii].
    Nakazono T; Sugie T; Ogata H; Mizutani S; Sugita H; Kino T; Wada M
    Kekkaku; 1994 Oct; 69(10):587-92. PubMed ID: 7799569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Agranulocytosis due to anti-tuberculosis drugs including isoniazid (INH) and rifampicin (RFP)--a report of four cases and review of the literature].
    Shishido Y; Nagayama N; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Komatsu H; Yotsumoto H
    Kekkaku; 2003 Nov; 78(11):683-9. PubMed ID: 14672045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [New drugs against tuberculosis and nontuberculous mycobacterial infections: a review].
    Amitani R; Kuze F
    Kekkaku; 1994 Nov; 69(11):711-7. PubMed ID: 7837725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Non-tuberculous mycobacteriosis. What has been coming out].
    Kajiki A
    Kekkaku; 2011 Feb; 86(2):113-25. PubMed ID: 21404655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of a newly developed broth microdilution test method to determine minimum inhibitory concentrations (MICs) of antimicrobial agents for mycobacteria].
    Yamane N; Nakasone I; Saitoh H; Kaneda M; Shimojima M; Yamashita K; Toyoda K; Okazawa Y
    Rinsho Byori; 1998 Jul; 46(7):719-27. PubMed ID: 9721542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mycobacterium kansasii lung infection associated with myelofibrosis--a case refractory to treatment with antitubercular agents].
    Umeda A; Asano K; Kawai A; Nakamura H; Fujita H; Mori M; Yamaguchi K; Kanazawa M
    Nihon Kyobu Shikkan Gakkai Zasshi; 1994 Dec; 32(12):1170-4. PubMed ID: 7853774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Perspective of pulmonary MAC infection treatment].
    Kurashima A
    Kekkaku; 2007 Mar; 82(3):195-9. PubMed ID: 17444124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [In vitro antimycobacterial activity of clarithromycin and its therapeutic efficacy against Mycobacterium intracellulare infection induced in mice].
    Tomioka H; Sato K; Saito H
    Kekkaku; 1993 Apr; 68(4):293-9. PubMed ID: 8497119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical features of pulmonary Mycobacterium kansasii infection: comparison with M. tuberculosis and M. avium complex infection].
    Matsushita Y; Niimi A; Tanaka E; Amitani R; Kurasawa T; Kawai M; Kuze F
    Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Dec; 31(12):1507-14. PubMed ID: 8121086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapeutic efficacy of macrolide in pulmonary nontuberculous mycobacteriosis].
    Tomono K
    Kekkaku; 1994 Nov; 69(11):725-32. PubMed ID: 7837727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [In vitro susceptibilities of Mycobacterium avium and Mycobacterium intracellulare to new macrolides, new quinolones, and antituberculous drugs on Dubos agar medium].
    Ogawa K; Miwa T; Sasamoto M; Sasaki T; Tsuda M; Honda K; Furui H; Torii K; Takagi K
    Kekkaku; 1992 Nov; 67(11):735-8. PubMed ID: 1487866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of combined chemotherapy following the guidelines on treatment for Mycobacterium avium complex pulmonary disease].
    Kobashi Y; Okimoto N; Matsushima T; Shigetou E; Kuraoka T; Takeyama H; Eda R; Yano S; Kobayashi K; Ohnishi T; Mori K; Ueda Y; Moritaka T; Nishimura K; Abe T
    Kekkaku; 2002 Jun; 77(6):435-41. PubMed ID: 12136597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A case of drug-resistant pulmonary tuberculosis treated successfully following disappearance of rifampicin resistance after 17 years' chemotherapy].
    Shigeto E; Murakami I; Yokosaki Y
    Kekkaku; 2001 Apr; 76(4):379-83. PubMed ID: 11398329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.